AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DIPHENHYDRAMINE HCL
6 registrations across 4 African markets— 3 active
Markets with DIPHENHYDRAMINE HCL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| STOPKOF- P SYRUP | 🇷🇼Rwanda | NATIONAL PHARMACEUTICAL INDUSTRIES CO.(SAOC) | active | Jul 2029 |
| LIPWORTH SLEEP CAPS 25 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Jun 2025 |
| BENYLIN_PAEDIATRIC 7MG SYRUP SYRUP | 🇲🇼Malawi | — | expired | Mar 2025 |
| BETASLEEP 50MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2024 |
| ALLERNIX PLUS comprimé / 50 g | 🇸🇳Senegal | TECHNILAB | active | — |
| ALLERNIX PLUS comprimé / 25 mg | 🇸🇳Senegal | TECHNILAB | active | — |
DIPHENHYDRAMINE HCL in Africa — Regulatory Overview
DIPHENHYDRAMINE HCL is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Senegal, Rwanda, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 3 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.